Results 21 to 30 of about 991 (120)

N‐terminal pro B‐type natriuretic peptide as biomarker to predict pre‐eclampsia and maternal–fetal complications

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 4, Page 447-455, April 2025.
ABSTRACT Objective A soluble fms‐like tyrosine kinase‐1 (sFlt‐1)‐to‐placental growth factor (PlGF) ratio cut‐off of 38 is currently considered optimal for ruling out pre‐eclampsia (PE); however, implementation of this ratio in clinical practice is limited.
M. N. Nan, C. Garrido‐Giménez, Á. Garcia‐Osuna, P. Garcia Manau, J. Ullmo, J. Mora, O. Sanchez‐Garcia, J. Platero, M. Cruz‐Lemini, E. Llurba, on behalf of the EuroPE working group, M. Vila‐Cortés, M. J. Pelegay, M. Ricart, B. Muñoz‐Abellana, X. Gabaldó Barrios   +15 more
wiley   +1 more source

Association of maternal body mass index with hemodynamic and vascular alterations at 35–37 weeks' gestation

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 3, Page 303-310, March 2025.
ABSTRACT Objective Globally, one in four pregnant women is classified as overweight or obese, based on their prepregnancy body mass index (BMI). Obese pregnant women are at increased risk of adverse pregnancy outcomes and long‐term cardiovascular disease that occurs earlier in life.
M. Charakida, C. Chatzakis, L. A. Magee, A. Syngelaki, T. Mansukhani, P. von Dadelszen, K. H. Nicolaides   +6 more
wiley   +1 more source

Prediction of pre‐eclampsia using maternal hemodynamic parameters at 12 + 0 to 15 + 6 weeks

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 2, Page 173-182, February 2025.
ABSTRACT Objectives To compare the maternal hemodynamic profile at 12 + 0 to 15 + 6 weeks' gestation in women who subsequently developed pre‐eclampsia (PE) and those who did not, and to assess the screening performance of maternal hemodynamic parameters for PE in combination with the Fetal Medicine Foundation (FMF) triple test, including maternal ...
X. Wang, D. S. Sahota, L. Wong, L. Nguyen‐Hoang, Y. Chen, A. S. T. Tai, F. Liu, S. Ling Lau, A. P. W. Lee, L. C. Poon   +9 more
wiley   +1 more source

Exploring pathophysiological insights to improve diagnostic utility of ultrasound markers for distinguishing placenta accreta spectrum from uterine‐scar dehiscence

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 1, Page 85-93, January 2025.
ABSTRACT Objective Accurate differentiation between placenta accreta spectrum (PAS) and uterine‐scar dehiscence with underlying non‐adherent placenta is often challenging, even for PAS experts, both prenatally and intraoperatively. We investigated the use of standardized two‐dimensional grayscale ultrasound and Doppler imaging markers in ...
T. Adu‐Bredu, R. A. Aryananda, S. Mathewlynn, S. L. Collins   +3 more
wiley   +1 more source

Intermanufacturer assessment of diagnostic performance of angiogenic ratio vs glycosylated fibronectin in women with suspected pre‐eclampsia

Ultrasound in Obstetrics &Gynecology, Volume 64, Issue 5, Page 620-625, November 2024.
ABSTRACT Objective To compare the diagnostic performance of different manufacturers' immunoassays for the soluble fms‐like tyrosine kinase‐1 (sFlt‐1)‐to‐placental growth factor (PlGF) ratio with that of a point‐of‐care (PoC) test for glycosylated fibronectin (GlyFn) in women with suspected pre‐eclampsia (PE).
I. Y. M. Wah, D. S. Sahota, N. K. L. Wong, N. M. W. Lee, C. J. Liu, C. S. L. Lau, H. H. Y. Leung, L. C. Poon   +7 more
wiley   +1 more source

Maternal ethnicity and socioeconomic deprivation: influence on adverse pregnancy outcomes

Ultrasound in Obstetrics &Gynecology, Volume 64, Issue 2, Page 187-192, August 2024.
ABSTRACT Objective To evaluate the relative importance of ethnicity and socioeconomic deprivation in determining the likelihood and prevalence of placentally derived composite of adverse pregnancy outcomes (CAPO) and composite of severe adverse pregnancy outcomes (CAPO‐S).
M. Minopoli, L. Noël, A. Dagge, G. Blayney, A. Bhide, B. Thilaganathan   +5 more
wiley   +1 more source

Prenatal prediction of adverse outcome using different charts and definitions of fetal growth restriction

Ultrasound in Obstetrics &Gynecology, Volume 63, Issue 5, Page 605-612, May 2024.
ABSTRACT Objective Antenatal growth assessment using ultrasound aims to identify small fetuses that are at higher risk of perinatal morbidity and mortality. This study explored whether the association between suboptimal fetal growth and adverse perinatal outcome varies with different definitions of fetal growth restriction (FGR) and different weight ...
M. Mascherpa, C. Pegoire, A. Meroni, M. Minopoli, B. Thilaganathan, A. Frick, A. Bhide   +6 more
wiley   +1 more source

Performance of machine‐learning approach for prediction of pre‐eclampsia in a middle‐income country

Ultrasound in Obstetrics &Gynecology, Volume 63, Issue 3, Page 350-357, March 2024.
ABSTRACT Objective Pre‐eclampsia (PE) is a serious complication of pregnancy associated with maternal and fetal morbidity and mortality. As current prediction models have limitations and may not be applicable in resource‐limited settings, we aimed to develop a machine‐learning (ML) algorithm that offers a potential solution for developing accurate and ...
J. Torres‐Torres, J. R. Villafan‐Bernal, R. J. Martinez‐Portilla, J. A. Hidalgo‐Carrera, G. Estrada‐Gutierrez, R. Adalid‐Martinez‐Cisneros, L. Rojas‐Zepeda, S. Acevedo‐Gallegos, D. M. Camarena‐Cabrera, M. Y. Cruz‐Martínez, S. Espino‐y‐Sosa   +10 more
wiley   +1 more source

Prenatal diagnosis and postnatal outcome of Type‐III vasa previa: systematic review of literature

Ultrasound in Obstetrics &Gynecology, Volume 63, Issue 1, Page 24-33, January 2024.
ABSTRACT Objective Type‐III vasa previa (VP) is a rare form of VP, not necessarily associated with other placental or vascular anomalies, in which aberrant vessels run from the placenta to the amniotic membranes, near the internal cervical os, before returning to the placenta. Early diagnosis of Type‐III VP is important but technically challenging. The
M. Pozzoni, C. Sammaria, R. Villanacci, C. Borgese, F. Ghisleri, A. Farina, M. Candiani, P. I. Cavoretto   +7 more
wiley   +1 more source

胎膜早破与阴道菌群及胎盘胎膜三者之关系的临床分析

Huli yanjiu, 2003
目的 :通过对胎膜早破及未破膜的孕妇阴道菌群及产后胎盘胎膜之间的比较 ,分析胎膜早破的原因。方法 :产前采集阴道分泌物做细菌培养、药敏试验 ,产后采集胎盘和胎膜组织做病理学检查。结果 :40例胎膜早破产妇和 40例未破膜两组比较 ,阴道菌群及产后的胎盘胎膜病理诊断有显著差异。结论 :胎膜早破与G-菌感染及胎盘胎膜炎性改变有一定的因果关系。
郝秀卿, 张幸花
doaj